Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New anticancer agent capable of eluding tumor resistance mechanisms

Feb. 25, 1998

PI-88 one step closer to clinical testing

Feb. 24, 1998

DBD meets with FDA to discuss dibromodulcitol progress

Feb. 24, 1998

Sponge-derived natural product shows promise as a new cancer therapeutic

Feb. 24, 1998

Recombinant methioninase shows clinical efficacy in depleting serum methionine

Feb. 24, 1998

Encouraging results obtained with Hycamtin in multiple myeloma

Feb. 23, 1998

In vitro study shows COX-1/COX-2 inhibition not associated with anticancer activity

Feb. 23, 1998

Pharmacia & Upjohn develops new antiproliferative agents

Feb. 23, 1998

PKC inhibitors under study at Hoechst Marion Roussel

Feb. 20, 1998

New natural or semisynthetic cytotoxic alkaloids from Indena

Feb. 19, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...